WHO ICTRP trial
Effect of Botolinium injection on symptoms reduction in patients with…
IRCT20130710013938N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20130710013938N4 |
|---|---|
| Public title | Effect of Botolinium injection on symptoms reduction in patients with Temporomandibular Disorders |
| Scientific title | Evaluation of Botolinium injection on symptoms reduction in patients with Temporomandibular Disorders |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Temporomandibular Disorder. Temporomandibular joint disorders |
| Interventions | Intervention group: Patients with Temporomandibular Disorder undergo total of 50 units of botulinum Dysport toxin injection at the trigger point in the masseter muscle. |
| Registration date | Apr 9, 2018 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: